IMPROVEMENTS IN MAJOR CLINICAL EVENTS IN CHILDREN TREATED WITH TRIHEPTANOIN FOR LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)

被引：0
|
作者：
Ray, Kathryn [1 ]
Pisani, Laura [1 ]
Lu, Xiaoxiao [1 ]
Vockley, Jerry [2 ]
机构：
[1] Ultragenyx Pharmaceut Inc, Novato, CA USA
[2] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
75
引用
收藏
页码：295 / 296
页数：2
相关论文
共 50 条
  • [21] Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
    Thomas Zöggeler
    Katharina Stock
    Monika Jörg-Streller
    Johannes Spenger
    Vassiliki Konstantopoulou
    Miriam Hufgard-Leitner
    Sabine Scholl-Bürgi
    Daniela Karall
    Orphanet Journal of Rare Diseases, 16
  • [22] Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
    Zoeggeler, Thomas
    Stock, Katharina
    Joerg-Streller, Monika
    Spenger, Johannes
    Konstantopoulou, Vassiliki
    Hufgard-Leitner, Miriam
    Scholl-Buergi, Sabine
    Karall, Daniela
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [23] The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation Disorders
    Lee, Sun Ku
    Gupta, Manju
    Shi, Jack
    McKeever, Kathleen
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (11): : 1325 - 1334
  • [24] Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial
    Gillingham, Melanie B.
    Heitner, Stephen B.
    Martin, Julie
    Rose, Sarah
    Goldstein, Amy
    El-Gharbawy, Areeg Hassan
    Deward, Stephanie
    Lasarev, Michael R.
    Pollaro, Jim
    DeLany, James P.
    Burchill, Luke J.
    Goodpaster, Bret
    Shoemaker, James
    Matern, Dietrich
    Harding, Cary O.
    Vockley, Jerry
    JOURNAL OF INHERITED METABOLIC DISEASE, 2017, 40 (06) : 831 - 843
  • [25] Regulatory news: Dojolvi (triheptanoin) as a source of calories and fatty acids in long-chain fatty acid oxidation disorders: FDA approval summary
    Zand, Dina
    Doan, Jenny
    Yi, Sojeong
    Wang, Jie
    Ma, Lian
    Akinshola, Emmanuel
    Chakder, Sushanta
    Meyer, Joette
    Pacanowski, Michael
    Johnson, Laura Lee
    Donohue, Kathleen
    Beitz, Julie
    JOURNAL OF INHERITED METABOLIC DISEASE, 2021, 44 (03) : 515 - 517
  • [26] DISORDERS OF MITOCHONDRIAL LONG-CHAIN FATTY-ACID OXIDATION
    POLLITT, RJ
    JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 (04) : 473 - 490
  • [27] Lactic acidosis in long-chain fatty acid β-oxidation disorders
    Ventura, FV
    Ruiter, JPN
    Ijlst, L
    De Almeida, IT
    Wanders, RJA
    JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (06) : 645 - 654
  • [28] Odd or even? Results from a randomized trial of triheptanoin compared to MCT in patients with long-chain fatty acid oxidation disorders
    Gillingham, Melanie B.
    Harding, Cary O.
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (03) : 320 - 321
  • [29] Triheptanoin in the management of long-chain fatty acid oxidation disorders: a profile of its use (vol 37, pg 187, 2021)
    Kim, Esther S.
    Keam, Susan J.
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (06) : 282 - 282
  • [30] Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)
    Vockley, Jerry
    Burton, Barbara
    Berry, Gerard T.
    Longo, Nicola
    Phillips, John
    Sanchez-Valle, Amarilis
    Tanpaiboon, Pranoot
    Grunewald, Stephanie
    Murphy, Elaine
    Bowden, Alexandra
    Chen, Wencong
    Chen, Chao-Yin
    Cataldo, Jason
    Marsden, Deborah
    Kakkis, Emil
    JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (01) : 169 - 177
12345